Literature DB >> 240775

Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: clinical and familial studies.

J L Vives-Corrons, C Rozman, A Kahn, A Carrera, J Triginer.   

Abstract

A new case of glucose phosphate isomerase deficiency associated with cogenital nonspherocytic hemolytic anemia is described in a 12-year-old girl of Spanish origin. The parents exhibited erythrocyte glucose phosphate isomerase activity between 50 and 60% of normal. The enzyme of the propositus had normal Michaelis-Menten constants both for F-6-P and G-6-P, but abnormal pH optimum and decreased heat stability at 48 degrees C. On starch-gel electrophoresis the father's enzyme was normal but the mother's showed a cathodic migrating band in addition to the normal one. The enzyme from the propositus exhibited only one band with cathodal mobility of 116% of the main band found in normal subjects. It is postulated that the propositus is double heterozygous for two abnormal alleles, and the mother contributes a mutant allele with abnormal electrophoretic mobility and thermolability at 48 degrees C whereas the father contributes an allele without enzymatic activity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240775     DOI: 10.1007/bf00394191

Source DB:  PubMed          Journal:  Humangenetik        ISSN: 0018-7348


  14 in total

1.  [DETERMINATION OF ERYTHROCYTE GLUTATHIONE BY AN AROMATIC NITRO DISULFIDE: 5,5'-DITHIOBIS-(2-NITROBENZOIC) ACID].

Authors:  J C KAPLAN; J C DREYFUS
Journal:  Bull Soc Chim Biol (Paris)       Date:  1964

2.  The glutathione instability of drug-sensitive red cells; a new method for the in vitro detection of drug sensitivity.

Authors:  E BEUTLER
Journal:  J Lab Clin Med       Date:  1957-01

3.  Autohemolysis and other changes resulting from the incubation in vitro of red cells from patients with congenital hemolytic anemia.

Authors:  J G SELWYN; J V DACIE
Journal:  Blood       Date:  1954-05       Impact factor: 22.113

4.  [Acquired erythroenzymopathies. I. Quantitative anomalies observed in 100 cases of various hemopathies].

Authors:  P Boivin; C Galand; M Audollent
Journal:  Pathol Biol (Paris)       Date:  1970-02

5.  Hereditary deficiency of glucosephosphate isomerase as a cause of nonspherocytic hemolytic anemia.

Authors:  G W Löhr; H Arnold; K G Blume; R Engelhardt; E Beutler
Journal:  Blut       Date:  1973-06

6.  Inherited variations in human phosphohexose isomerase.

Authors:  J C Detter; P O Ways; E R Giblett; M A Baughan; D A Hopkinson; S Povey; H Harris
Journal:  Ann Hum Genet       Date:  1968-05       Impact factor: 1.670

7.  Occurrence of defective hexosephosphate isomerization in human erythrocytes and leukocytes.

Authors:  D E Paglia; P Holland; M A Baughan; W N Valentine
Journal:  N Engl J Med       Date:  1969-01-09       Impact factor: 91.245

8.  Glycolysis and glycolytic enzyme activity of aging red cells in man. Changes in hexokinase, aldolase, glyceraldehyde-3-phosphate dehydrogenase, pyruvate kinase and glutamic-oxalacetic transaminase.

Authors:  R G Chapman; L Schaumburg
Journal:  Br J Haematol       Date:  1967-09       Impact factor: 6.998

9.  Electrophoretic and kinetic studies of glucosephosphate isomerase (GPI) in two different Japanese families with GPI deficiency.

Authors:  K Nakashima; S Miwa; S Oda; E Oda; N Matsumoto
Journal:  Am J Hum Genet       Date:  1973-05       Impact factor: 11.025

10.  Characterization of two new variants of glucose-phosphate-isomerase deficiency with hereditary nonspherocytic hemolytic anemia.

Authors:  K G Blume; W Hryniuk; D Powars; F Trinidad; C West; E Beutler
Journal:  J Lab Clin Med       Date:  1972-06
View more
  11 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

2.  Biochemical genetics of a new glucosephosphate isomerase allele (Gpi-1c) from wild mice.

Authors:  R A Padua; G Bulfield; J Peters
Journal:  Biochem Genet       Date:  1978-02       Impact factor: 1.890

Review 3.  Inherited glucosephosphate isomerase deficiency. A review of known variants and some aspects of the pathomechanism of the deficiency.

Authors:  H Arnold
Journal:  Blut       Date:  1979-12

4.  Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: clinical, genetic and molecular studies in six new Spanish patients.

Authors:  J L Vives-Corrons; J Marie; M A Pujades; A Kahn
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

5.  GPI Mount Scopus--a variant of glucosephosphate isomerase deficiency.

Authors:  O Shalev; R S Shalev; L Forman; E Beutler
Journal:  Ann Hematol       Date:  1993-10       Impact factor: 3.673

6.  Triosephosphate isomerase deficiency with hemolytic anemia and severe neuromuscular disease: familial and biochemical studies of a case found in Spain.

Authors:  J L Vives-Corrons; H Rubinson-Skala; M Mateo; J Estella; E Feliu; J C Dreyfus
Journal:  Hum Genet       Date:  1978-06-09       Impact factor: 4.132

7.  'GPI Roma', a new glucose phosphate isomerase deficient variant: in vivo occurrence of postsynthetic modifications of the mutant enzyme.

Authors:  G Isacchi; D Cottreau; F Mandelli; G Papa; F Ciccone; A Kahn
Journal:  Hum Genet       Date:  1979-01-25       Impact factor: 4.132

8.  Hereditary hemolytic anemia with erythrocyte pyrimidine 5'-nucleotidase deficiency in Spain. Clinical, biological and familial studies.

Authors:  J L Vives-Corrons; E Montserrat-Costa; C Rozman
Journal:  Hum Genet       Date:  1976-12-15       Impact factor: 4.132

Review 9.  [Enzyme deficiencies in glycolysis and nucleotide metabolism of red blood cells in nonspherocytic hemolytic anemia (author's transl)].

Authors:  H D Waller; H C Benöhr
Journal:  Klin Wochenschr       Date:  1976-09-01

10.  Molecular and functional anomalies in two new mutant glucose-phosphate-insomerase variants with enzyme deficiency and chronic hemolysis.

Authors:  A Kahn; H A Buc; R Girot; D Cottreau; C Griscelli
Journal:  Hum Genet       Date:  1978-02-16       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.